AU2015287447A1 - Analyte concentration measurement - Google Patents
Analyte concentration measurement Download PDFInfo
- Publication number
- AU2015287447A1 AU2015287447A1 AU2015287447A AU2015287447A AU2015287447A1 AU 2015287447 A1 AU2015287447 A1 AU 2015287447A1 AU 2015287447 A AU2015287447 A AU 2015287447A AU 2015287447 A AU2015287447 A AU 2015287447A AU 2015287447 A1 AU2015287447 A1 AU 2015287447A1
- Authority
- AU
- Australia
- Prior art keywords
- potential
- cycle
- mediator
- concentration
- test meter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000005259 measurement Methods 0.000 title claims abstract description 30
- 239000012491 analyte Substances 0.000 title claims abstract description 21
- 238000009825 accumulation Methods 0.000 claims abstract description 31
- 238000006479 redox reaction Methods 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 28
- 239000008364 bulk solution Substances 0.000 claims abstract description 13
- 230000007423 decrease Effects 0.000 claims abstract description 11
- 238000012360 testing method Methods 0.000 claims description 31
- 230000003647 oxidation Effects 0.000 claims description 24
- 238000007254 oxidation reaction Methods 0.000 claims description 24
- 230000009467 reduction Effects 0.000 claims description 22
- 230000000977 initiatory effect Effects 0.000 claims description 17
- 238000009792 diffusion process Methods 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 7
- 230000002452 interceptive effect Effects 0.000 abstract description 3
- 238000005534 hematocrit Methods 0.000 abstract description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 19
- 239000008103 glucose Substances 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 16
- 230000035945 sensitivity Effects 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000000116 mitigating effect Effects 0.000 description 7
- 238000013459 approach Methods 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3274—Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Electrochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
A method of determining analyte concentration uses a redox reaction in an electrochemical cell that has at least two electrodes, one of which is a working electrode, at least one electrode being exposed to at least one redox mediator. The method uses at least one cycle of pulses, each cycle having at least a first potential and a second potential. The method comprises applying a first potential to initiate an accumulation phase that forces accumulation of a mediator concentration gradient at or close to the working electrode with a concentration that decreases towards the bulk solution, applying a second potential to initiate a measurement phase and deplete the established mediator concentration gradient at the working electrode, measuring current associated with the second potential of each cycle, and using the measured current to determine analyte concentration. In this way, the effects of diffusion interfering factors (DIF), especially haematocrit (Hct) can be mitigated.
Description
WO 2016/005743 PCT/GB2015/051973 1
Analyte Concentration Measurement
Field of the Invention
The present invention relates to a diffusion based analyte concentration measurement 5 that mitigates the effects of diffusion interfering factors.
Background of the Invention
Electrochemical-based sensors, such as self-monitoring blood glucose (SMBG) strips, are used for measuring/determining analyte concentration in fluid samples, for example 10 whole blood. However, their accuracy can suffer from diffusion interfering factors (DIF), which affect analyte mass transfer in the test fluids, e.g. blood haematocrit (Hct) because red blood cells block diffusion pathway of the analyte (e.g. glucose). There is a need to develop technologies for DIF mitigation to meet product accuracy requirements. 15 DIF mitigation can be categorized into active approaches and passive approaches. The former relies on using DIF sensitive signals to have DIF “measurements” which are then used for DIF correction. A problem with active approaches is that they require extra mechanisms, such as additional strip elements, more measurement steps, and 20 additional device/meter components/parts. In contrast, passive approaches use DIF insensitive signals or signals with negligible DIF effect for the analyte measurement. US8105478B2 describes a method for selecting pulse lengths for measuring the concentration of a redox-active substance as a mediator in a molecular-biological 25 detection system, in which suitable potentials are applied to a working electrode, to cause at least one of an oxidation process and a reduction process, which takes place as a redox reaction. The method comprises pulsing the potential of the working electrode and alternately forming measuring phases and relaxation phases; selecting the measuring-phase pulse lengths so that, towards the end of the pulse, the capacitive 30 current is relatively small in comparison with the Faraday current; and selecting the relaxation-phase pulse lengths so that, towards the end of the pulse, the concentration gradient is relaxed so that at the beginning of a following measuring phase, the change in concentration of the mediator, brought about by the consumption of the mediator by the measurement itself, is reversed to the greatest possible extent approaching the 35 original level. WO 2016/005743 PCT/GB2015/051973 2
Summary of the invention
According to the present invention, there is provided a method of reducing or mitigating the effects of DIF in a method of determining analyte concentration using a redox 5 reaction in an electrochemical cell that has at least two electrodes, one of which is a working electrode, at least one electrode being exposed to at least one redox mediator, using at least one cycle of pulses, each cycle having a first potential and a second potential, the method comprising: applying a first potential to initiate an accumulation phase that forces accumulation of a concentration gradient of the mediator at or close 10 to the working electrode with a concentration that decreases towards the bulk solution; applying a second potential to initiate a measurement phase and deplete the established concentration gradient of the mediator; and measuring current associated with the second potential of each cycle during depletion of the established concentration gradient. The measured current can be used to calculate analyte 15 concentration.
By forcing establishment of a concentration gradient of mediator with a concentration that decreases towards the bulk solution at the working electrode in an accumulation phase of the cycle, for glucose testing current sensitivity to Hct is reduced, whilst 20 current sensitivity to glucose is enhanced.
The concentration gradient may gradually and continuously decrease towards the bulk solution. Alternatively, the concentration gradient may fluctuate, whilst generally decreasing towards the bulk solution. 25
The at least one electrode may be coated with at least one redox mediator. Alternatively or additionally, the electrode may be in a solution that includes at least one redox mediator, and so is exposed to the at least one redox mediator. 30 The accumulation phase can have a reduction at the working electrode and the measurement phase can have an oxidation at the working electrode. Alternatively, the accumulation phase may have an oxidation and the measurement phase can have a reduction at the working electrode depending on nature of redox reaction involving the analyte and mediator(s). As is known in the art, whether the accumulation phase 35 should have reduction or oxidation depends on the mediator state (oxidised or PCT/GB2015/051973 WO 2016/005743 3 reduced) before it undergoes the heterogeneous reaction at electrode surface. Also, it will be appreciated that more than one mediator may be used for a series of redox reactions.
In addition to the first and second potentials, further potentials may be applied to the 5 electrode(s). Such further potentials could be applied before the first potential or after the second potential. For example, an initiation potential may be applied prior to applying the at least one cycle of pulses, wherein the initiation potential has an open circuit or potential for substantially no redox reaction at the electrodes. The initiation potential may be applied prior to applying each cycle of pulses. In all cases, the 10 second potential has to immediately follow the first potential, so that the accumulation phase that forces accumulation of the concentration gradient immediately precedes the measurement phase.
The second potential is such that after depletion of the established concentration gradient of the mediator another concentration gradient of the mediator builds up (the 15 opposite concentration gradient is established), but with a concentration that increases towards the bulk solution.
The magnitudes of the first potential and the second potential may be symmetrical relative to a potential which elicits substantially zero current flow (E0). The magnitudes 20 of the first potential and second potential may be asymmetrical to E0.
Durations of the first potential and the second potential may be the same. Durations of the first potential and the second potential may be different. Durations of the first potential and the second potential may be less than 10 minutes, preferably less than 1 25 minute, and most preferably less than 5 seconds. Durations of the first potential and the second potential may be between 5 to 100% of the total time of each pulse cycle.
According to another aspect of the invention, there is provided a test meter for determining analyte concentration using a redox reaction in an electrochemical cell that 30 has at least two electrodes, one of which is a working electrode, at least one electrode exposed to at least a redox mediator, using at least one cycle of pulses, each cycle having a first potential and a second potential, the meter being configured to: apply a first potential to initiate an accumulation phase that forces accumulation of a concentration gradient of the mediator at or close to the working electrode with a 35 concentration that decreases towards the bulk solution; apply a second potential to PCT/GB2015/051973 WO 2016/005743 4 initiate a measurement phase and deplete the established concentration gradient of the mediator; and measure current associated with the second potential of each cycle. Preferably, the test meter is configured to calculate analyte concentration using the measured current. 5
The accumulation phase can be a reduction and the measurement phase can be an oxidation. Alternatively, the accumulation phase can be an oxidation and the measurement phase can be a reduction depending on the nature of the redox reaction involving the analyte and mediator(s). Also, it will be appreciated that more than one 10 mediator may be used for a series of redox reactions.
The second potential may be such that after depletion of the established concentration gradient of the mediator another concentration gradient of the mediator builds up, but with a concentration that increases towards the bulk solution. 15
The magnitudes of the first potential and the second potential may be symmetrical relative to a potential that causes substantially zero current flow (E0). The magnitudes of the first potential and second potential may be asymmetrical to E0. 20 Durations of the first potential and the second potential may be the same. Durations of the first potential and the second potential may be different. Durations of the first potential and the second potential may be less than 10 minutes, preferably less than 1 minute, and most preferably less than 5 seconds. Durations of the first potential and the second potential may be between 5 to 100% of the total time for each pulse cycle. 25
Brief Description of the Drawings
Various aspects of the invention will now be described by way of example only, and with reference to the following drawings, of which:
Figure 1 shows switching redox reactions at two electrodes by controlling 30 potential;
Figure 2 shows an evolution of Mred (reduced mediator) concentration gradient at the working electrode E1 with the redox reaction switch in Figure 1;
Figure 3 shows a test waveform and a control waveform for applying to the electrodes of an electrochemical cell; PCT/GB2015/051973 WO 2016/005743 5
Figure 4 shows current sensitivity to glucose versus measurement time for various samples taken using the waveforms of Figure 3, where the numbers in the legends are Hct levels as a percentage, and
Figure 5 shows the percentage biases to the nominal Hct of current sensitivity 5 to glucose at 0.3 seconds of four of the oxidation pulses of the waveforms of Figure 3, where the numbers in legends are the pulse numbers of the waveforms in Figure 3.
Detailed Description of the Drawings
This present invention mitigates the effects of DIF current signals by switching and 10 controlling redox reactions at the working and counter electrodes of electrochemical-based sensors that use mediators. This is done by creating a higher concentration of mediator near the working electrode than in the bulk sample during an accumulation phase, so that a mediator concentration gradient is present at the start of each measurement phase. Ideally, the mediator concentration gradient extends by at least 15 10nm from the working electrode into the bulk sample. The mediator concentration gradient should not reach the counter electrode, and so ideally the maximum extent of the mediator gradient is less than the separation of the working and counter electrodes. In many practical implementations, it is preferred that by the end of the accumulation phase and the start of the measurement phase, the mediator concentration gradient 20 does not extend to beyond half way between the working and counter electrodes.
Figure 1 shows one pulse cycle and the initiated corresponding redox reactions of an electrochemical test strip with two electrodes, a working electrode E1 and a counter electrode E2. The two electrodes are covered with a reagent layer which contains 25 redox mediator (M) and enzyme (Enz). To test the strip, the working and counter electrodes E1 and E2 respectively are in contact with a whole blood sample and an electrical potential (voltage) is applied between the two electrodes. This results in redox reactions both in the blood (homogeneous redox reactions) and at surfaces of the two electrodes (heterogeneous redox reactions). 30
For the heterogeneous redox reactions, oxidation occurs at one electrode and reduction at the other simultaneously. In Figure 1, the potential is applied as a series of square waves (pulses). The redox reactions at the two electrodes are switched over by altering the pulses from a reduction potential (Ered) to an oxidation potential (Eox). 35 This can be done by controlling the magnitude of the potential and, if necessary, PCT/GB2015/051973 WO 2016/005743 6 polarity. E0 is a potential for substantially zero redox reactions (neither reduction nor oxidation). Ered bias (difference) to E0 and Eox bias to E0 can be the same (i.e. symmetrical to E0 as illustrated in Figure 1) or different. 5 As illustrated in Figure 1, under Ered, oxidized mediator (Mox) undertakes reduction at the working electrode E1 (reaction 3), whilst reduced mediator (Mred) undertakes oxidation at the counter electrode E2 (reaction 2). At the same time, glucose (Glue) reacts with Mox involving the enzyme (Enz) to produce Mred in blood (reaction 1). As a result, Mred is “accumulated” at the working electrode E1 (both reactions 1 and 3 10 produce Mred) to a concentration C, higher than the starting Mred concentration C0 and a Mred concentration gradient is established with decreasing Mred concentration from the working electrode E1 surface towards the bulk solution (see Figure 2A to 2B). The Mred concentration gradient can be expressed as: Cg = (C, - C0)/ d,. A larger Cg means more Mred are retained closer to the electrode surface. 15
In addition to rates of reactions 1 and 3 (Figure 1), which are proportional to glucose concentration, Cg is dependent on Hct. The higher Hct, the slower Mred diffusion away from the electrode surface and hence, the larger Cg is established during the reduction pulse. 20
Upon changing from Ered to Eox, the heterogeneous redox reactions at the two electrodes are switched over (see Figure 1). In case of using the oxidation pulse (under Eox) for glucose measuring, glucose concentration is determined by measuring the rate of reaction 5, e.g. by measuring current. Rate of reaction 5 is proportional to 25 Mred available at the surface of the working electrode E1. Reaction 5 proceeds at a sufficiently high rate to cause Mred depletion to be faster than its supply (through diffusion) at the surface of the working electrode E1. This means that Mred concentration drops from C,, through C0, ultimately to Czero (see the dotted concentration gradient line in Figure 2C) with time. After the Mred concentration at the 30 surface of the working electrode E1 decreases below C0, Cg is negative and the rate of reaction 5 decreases with time in a pattern described by the Cottrell equation (see below), and the glucose measurement is Hct dependent. nFAVZ) ~^rc° WO 2016/005743 PCT/GB2015/051973 7
Here, i is the rate of reaction 5 expressed as current (amps); n is the number of electrons transferred in the heterogeneous redox reaction; Fis the Faraday constant (96485 Coulombs/mol); A is the electrode area (cm2); D is the diffusion coefficient 5 (cm2/sec); t is the test time (sec); and C0 is the reactant starting concentration (mol/cm3).
Over the time window that Cg is positive the rate of reaction 5 is dependent on Mred diffusion and the Mred concentration gradient established during the previous reduction 10 pulse. Increasing Hct decreases Mred diffusion, but increases the Mred concentration gradient. Therefore, the Hct effect on the glucose measurement is compensated by manipulating the redox reaction switch. To benefit from this compensated measurement, the current has to be measured in the concentration gradient depletion phase only, i.e. while the concentration gradient is being depleted. After the depletion 15 phase, when the mediator concentration drops below its start level (i.e. the level prior to the accumulation phase), the current becomes Hct dependent.
Establishment of the Mred concentration gradient during the accumulation phase can be achieved in various ways, including, but not limited to, controlling the potential 20 magnitude and/or polarity of the pulses applied, controlling the effective surface ratio of the two electrodes, controlling the pulse time, controlling reagent layer components and quantity ratios, or any combination of these. In the following examples, the potential magnitude of the pulses applied is used to force accumulation of the mediator concentration gradient and subsequently deplete the established mediator 25 concentration gradient at the working electrode. However, other techniques for controlling the accumulation and depletion of mediator concentration are possible.
Figure 3 shows a control waveform W69 and test waveform W70. The difference between the test waveform W70 and the control waveform W69 is that the test waveform W70 has a higher potential magnitude for the reduction pulses (pulses 2, 4, 30 6, 8) than the control waveform W69 to enhance the establishment of Mred concentration gradient at the working electrode E1 during these pulses (see Figure 1).
Both the oxidation and reduction pulses of the test waveform are over-potential. By this it is meant that the potential is of a magnitude that is sufficient for the redox PCT/GB2015/051973 WO 2016/005743 8 reactions at the electrodes to be dominated by diffusion of the mediator and/or analyte towards the electrode. Magnitudes of the oxidation and reduction pulses are selected and controlled by taking into account the electrochemical properties of the mediator and the electrodes. Both the oxidation and reduction pulses can have positive, negative 5 or zero potentials.
Each waveform of Figure 3 has 9 square pulses. At the working electrode E1, pulses 2, 4, 6, 8 lead to reduction (negative current in Figure 4) and pulses 3, 5, 7, 9 lead to oxidation (positive current in Figure 4). Pulse 1 is an initiation pulse that is applied once 10 before the start of the repeated cycles of pulses (i.e. it is not part of the repeated cycle of pulses). Pulse 1 is an under-potential pulse wherein the rate of redox reactions at the electrodes is dominated by the kinetics of the heterogeneous redox reactions to allow hydration/dissolution of the strip reagent layer (potential of this pulse can be E0or close to E0 to keep redox reaction at both the working electrode E1 and the counter 15 electrode E2 to a minimum). Pulse 1 can also be an open circuit.
The total test time of the 9 pulses in this experiment was designed for 6.25 seconds, but the test can be completed in 5 seconds (i.e. without pulses 8 and 9) or less. The waveforms were applied to the strip using a potentiostat, so that a positive potential 20 lead to oxidation and a negative/zero potential leads to reduction at the working electrode E1. The oxidation current (i.e. positive pulse current resulting from reaction 5 in Figure 1) is used for glucose measurement. Techniques for determining glucose concentration using current measured during a redox reaction are well known in the art and so will not be described in detail. 25
Laboratory test results of W69 and W70 current transients are shown in Figure 4. The top row and the bottom row of Figure 4 show plots of current sensitivity to glucose (i.e. current in Amp generated per mg/dL glucose) against test time at five targeted glucose concentrations (TG) for W69 and W70, respectively. For each target glucose 30 concentration, the same blood sample was tested for W69 and W70. Each line in the graphs represents mean current sensitivity of 6 replications. Each graph shows five mean current sensitivities at five target Hct levels (from 20% to 60%).
Figure 4 shows that in each graph of W69, there are clear separations between the 35 lines of positive pulses (measuring pulses). Higher Hct corresponds to lower current PCT/GB2015/051973 WO 2016/005743 9 sensitivity. This indicates that W69 measuring currents are sensitive to Hct variation. In contrast, for the graphs of W70, the line separation disappears or is remarkably decreased, i.e. Hct as a DIF is effectively accounted for. 5 W70 leads to significantly higher current sensitivity than W69, i.e. W70 has enhanced current sensitivity to glucose compared to W69. The enhancement in current sensitivity is twofold: 1) W70 lines in Figure 4 have higher magnitude than W69 lines; 2) W70 lines of each pulse have similar/close magnitude (they are on top of each other if overlaid) whilst W69 lines of each pulse decreases with time, i.e. W70 retains current 10 sensitivity throughout the test time whilst W69 does not. This is because the established Mred concentration gradient during the reduction pulse leads to enhanced reaction 5 of the subsequent oxidation pulse.
Figure 5 also show the mitigation of Hct, where percentage bias is the difference in 15 current sensitivity between the Hct of interest and the nominal Hct (defined here as 42%, and so this has zero bias). As an example, the current sensitivity at 0.3 seconds of the oxidation pulses 3, 5, 7 and 9 (see Figure 3) are used. For W69 results, the bias to nominal Hct had a range of about 20% to -20% with increased Hct. In contrast, for W70 results, the bias to nominal Hct was reduced with a range less than +/-10%. 20
The above described embodiment uses control of the pulse magnitude to force the establishment of the concentration gradient. However, DIF mitigation, and in particular Hct mitigation, can be achieved by other means. For example, this could be done by increasing the effective surface ratio of the counter electrode E2 to the working 25 electrode E1, or increasing the duration of the accumulation phase pulses. Indeed, any technique that forces the accumulation of a concentration gradient of the mediator at the working electrode E1 could be used.
The present invention provides a simple and effective technique for mitigating the 30 effects of DIF providing an Hct insensitive measurement. The method could be applied to existing products without making any changes to the strips. A skilled person will appreciate that variations of the disclosed arrangements are possible without departing from the invention. For example, although the invention has 35 been described with reference to a test strip with only two electrodes, the invention PCT/GB2015/051973 WO 2016/005743 10 could equally be applied to strips with three or more electrodes. Equally, whilst in the specific tests conducted only a single initiation pulse was used, an initiation pulse could be applied prior to every cycle of accumulation and measurement pulses. Accordingly the above description of the specific embodiment is made by way of example only and 5 not for the purposes of limitation. It will be clear to the skilled person that minor modifications may be made without significant changes to the operation described.
Claims (27)
1. A method of determining analyte concentration using a redox reaction in an electrochemical cell that has at least two electrodes, one of which is a working electrode, at least one electrode being exposed to at least one redox mediator, using at least one cycle of pulses, each cycle having at least a first potential and a second potential, the method comprising: applying a first potential to initiate an accumulation phase that forces accumulation of a mediator concentration gradient at or close to the working electrode with a concentration that decreases towards the bulk solution; applying a second potential to initiate a measurement phase and deplete the established mediator concentration gradient at the working electrode; measuring current associated with the second potential of each cycle, and using the measured current to determine analyte concentration.
2. A method as claimed in claim 1, wherein the accumulation phase is a reduction and the measurement phase is an oxidation.
3. A method as claimed in claim 1, wherein the accumulation phase is an oxidation and the measurement phase is a reduction.
4. A method as claimed in any of the preceding claims, wherein the second potential is such that after depletion of the established concentration gradient of the mediator another concentration gradient of the mediator builds up, but with a concentration that increases towards the bulk solution.
5. The method of the preceding claims, wherein the first potential and the second potential have magnitudes that are symmetrical relative to a potential that causes substantially zero current flow.
6. A method as claimed in any of claims 1 to 5, wherein the first potential and second potential have magnitudes that are asymmetrical relative to a potential that causes substantially zero current flow.
7. A method as claimed in any of the preceding claims, wherein durations of the first potential and the second potential are the same or different.
8. A method as claimed in any of the preceding claims comprising applying an initiation pulse prior to applying the at least one cycle of pulses, wherein the initiation pulse is an open circuit or a potential that causes substantially no redox reaction at the electrodes.
9. A method as claimed in claim 8, wherein an initiation pulse is applied prior to applying each cycle of pulses.
10. A method as claimed in claim 8 or claim 9, wherein the initiation pulse has a duration between zero to 20 minutes, preferably zero to 5 minutes, and most preferably zero to 5 seconds.
11. A method as claimed in claim 9 or claim 10, wherein the initiation pulse has a duration of between zero to 95 percent of the total time of each pulse cycle.
12. A method as claimed in any of the preceding claims, wherein durations of the first potential and the second potential are less than 10 minutes, preferably less than 1 minute, and most preferably less than 5 seconds.
13. A method as claimed in any of the preceding claims, wherein durations of the first potential and the second potential are between 5 to 100 percent of the total time of each pulse cycle.
14. A test meter for determining analyte concentration using a redox reaction in an electrochemical cell that has at least two electrodes, one of which is a working electrode, at least one electrode being exposed to at least a redox mediator, using at least one cycle of pulses, each cycle having a first potential and a second potential, the meter being configured to: apply a first potential to initiate an accumulation phase and force accumulation of a mediator concentration gradient at or close to the working electrode with a concentration that decreases towards the bulk solution; apply a second potential to initiate a measurement phase and deplete the established mediator concentration gradient at the working electrode; measure current associated with the second potential of each cycle, and use the measured current to determine analyte concentration
15. A test meter as claimed in claim 14, wherein the accumulation phase is a reduction and the measurement phase is an oxidation.
16. A test meter as claimed in claim 14, wherein the accumulation phase is an oxidation and the measurement phase is a reduction.
17. A test meter as claimed in any of claims 14 to 16, wherein the second potential is such that after depletion of the accumulated mediator concentration gradient another concentration gradient of the mediator at the working electrode builds up, but with a concentration that increases towards the bulk solution.
18. A test meter as claimed in any of claims 14 to 17 configured to calculate analyte concentration using the recorded current.
19. A test meter as claimed in any of claims 14 to 18, wherein the first potential and the second potential have magnitudes that are symmetrical relative to a potential that causes substantially zero current flow.
20. A test meter as claimed in any of claims 14 to 19, wherein magnitudes of the first potential and second potential are asymmetrical relative to a potential that causes substantially zero current flow.
21. A test meter as claimed in any of claims 14 to 20, wherein durations of the first potential and the second potential are the same or different.
22. A test meter as claimed in any of claims 14 to 21 adapted to apply an initiation pulse prior to applying the at least one cycle of pulses, wherein the initiation pulse is an open circuit or a potential that causes substantially no redox reaction at the electrodes.
23. A test meter as claimed in claim 22 adapted to apply an initiation pulse prior to applying each cycle of pulses, so that each cycle includes an initiation potential as well as first and second potentials.
24. A test meter as claimed in claim 22 or claim 23, wherein the initiation pulse has a duration between zero to 20 minutes, preferably zero to 5 minutes, and most preferably zero to 5 seconds.
25. A test meter as claimed in claim 24, wherein the initiation pulse has a duration of between zero to 95 percent of the total time of each pulse cycle.
26. A test meter as claimed in any of claims 14 to 25, wherein durations of the first potential and the second potential are less than 10 minutes, preferably less than 1 minute, and most preferably less than 5 seconds.
27. A test meter as claimed in any of claims 14 to 26, wherein the combined duration of the first potential and the second potential is between 5 to 100 percent of the total time for each pulse cycle.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1412156.0 | 2014-07-08 | ||
GBGB1412156.0A GB201412156D0 (en) | 2014-07-08 | 2014-07-08 | Analyte concentration measurement |
PCT/GB2015/051973 WO2016005743A1 (en) | 2014-07-08 | 2015-07-08 | Analyte concentration measurement |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2015287447A1 true AU2015287447A1 (en) | 2016-12-22 |
Family
ID=51410820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2015287447A Abandoned AU2015287447A1 (en) | 2014-07-08 | 2015-07-08 | Analyte concentration measurement |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP3167282A1 (en) |
JP (1) | JP6619367B2 (en) |
KR (1) | KR20170028408A (en) |
CN (1) | CN106687803A (en) |
AU (1) | AU2015287447A1 (en) |
BR (1) | BR112017000305A2 (en) |
CA (1) | CA2953452A1 (en) |
GB (1) | GB201412156D0 (en) |
RU (1) | RU2680266C2 (en) |
WO (1) | WO2016005743A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4368991A3 (en) | 2015-08-25 | 2024-08-14 | Avails Medical, Inc. | Devices, systems and methods for detecting viable microorganisms in a fluid sample |
EP4397973A3 (en) | 2016-05-31 | 2024-09-04 | Avails Medical, Inc. | Devices, systems and methods to detect viable infectious agents in a fluid sample and susceptibility of infectious agents to anti-infectives |
US20180306744A1 (en) * | 2017-04-20 | 2018-10-25 | Lifescan Scotland Limited | Analyte measurement system and method |
WO2019005296A1 (en) | 2017-06-27 | 2019-01-03 | Avails Medical, Inc. | Apparatus, systems, and methods for determining susceptibility of microorganisms to anti-infectives |
EP3668650A4 (en) * | 2017-10-03 | 2021-06-02 | Avails Medical, Inc. | Apparatus, systems, and methods for determining the concentration of microorganisms and the susceptibility of microorganisms to anti-infectives based on redox reactions |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7455975B2 (en) * | 2000-04-14 | 2008-11-25 | Esa Biosciences, Inc. | Electrochemical detection of nucleic acid sequences |
RU2267120C2 (en) * | 2000-07-14 | 2005-12-27 | Лайфскен, Инк. | Electrochemical mode of measuring of speed of chemical reactions |
GB0211449D0 (en) * | 2002-05-17 | 2002-06-26 | Oxford Biosensors Ltd | Analyte measurement |
WO2005073708A2 (en) * | 2004-01-29 | 2005-08-11 | Siemens Aktiengesellschaft | Method for measuring the concentration or change in concentration of a redox-active substance and corresponding device |
EP1751533A2 (en) * | 2004-05-14 | 2007-02-14 | Bayer Healthcare, LLC | Voltammetric systems for assaying biological analytes |
US7749371B2 (en) * | 2005-09-30 | 2010-07-06 | Lifescan, Inc. | Method and apparatus for rapid electrochemical analysis |
ES2397663T3 (en) * | 2006-10-05 | 2013-03-08 | Lifescan Scotland Limited | Systems and procedures for determining a concentration of an analyte substantially independent of hematocrit |
US8603768B2 (en) * | 2008-01-17 | 2013-12-10 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
WO2012012341A1 (en) * | 2010-07-19 | 2012-01-26 | Cilag Gmbh International | System and method for measuring an analyte in a sample |
US9201038B2 (en) * | 2012-07-24 | 2015-12-01 | Lifescan Scotland Limited | System and methods to account for interferents in a glucose biosensor |
US9005426B2 (en) * | 2012-09-28 | 2015-04-14 | Cilag Gmbh International | System and method for determining hematocrit insensitive glucose concentration |
GB2515299B (en) * | 2013-06-18 | 2015-12-30 | Suresensors Ltd | Methods and apparatus for determining analyte in a sample |
-
2014
- 2014-07-08 GB GBGB1412156.0A patent/GB201412156D0/en not_active Ceased
-
2015
- 2015-07-08 WO PCT/GB2015/051973 patent/WO2016005743A1/en active Application Filing
- 2015-07-08 EP EP15747510.4A patent/EP3167282A1/en not_active Withdrawn
- 2015-07-08 BR BR112017000305A patent/BR112017000305A2/en not_active Application Discontinuation
- 2015-07-08 CN CN201580037065.6A patent/CN106687803A/en active Pending
- 2015-07-08 JP JP2016573879A patent/JP6619367B2/en not_active Expired - Fee Related
- 2015-07-08 CA CA2953452A patent/CA2953452A1/en not_active Abandoned
- 2015-07-08 AU AU2015287447A patent/AU2015287447A1/en not_active Abandoned
- 2015-07-08 RU RU2017103730A patent/RU2680266C2/en not_active IP Right Cessation
- 2015-07-08 KR KR1020177003207A patent/KR20170028408A/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2680266C2 (en) | 2019-02-19 |
JP2017519990A (en) | 2017-07-20 |
BR112017000305A2 (en) | 2017-10-31 |
EP3167282A1 (en) | 2017-05-17 |
CN106687803A (en) | 2017-05-17 |
RU2017103730A (en) | 2018-08-08 |
KR20170028408A (en) | 2017-03-13 |
RU2017103730A3 (en) | 2019-01-14 |
GB201412156D0 (en) | 2014-08-20 |
CA2953452A1 (en) | 2016-01-14 |
JP6619367B2 (en) | 2019-12-11 |
WO2016005743A1 (en) | 2016-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10908112B2 (en) | Rapid-read gated amperometry devices | |
AU2015287447A1 (en) | Analyte concentration measurement | |
EP2016399B1 (en) | Method for determining underfill in an electrochemical biosensor and underfill detection system | |
RU2647473C2 (en) | Systems and methods for improved stability of electrochemical sensors | |
EP3011323B1 (en) | Methods and apparatus for determining analyte in a sample using a sensor having electrodes which are provided with an enzyme and a mediator | |
RU2002116217A (en) | ELECTROCHEMICAL METHOD AND DEVICES INTENDED FOR APPLICATION WHEN DETERMINING THE CONCENTRATIONS OF THE SUBSTANCES TESTED WITH CORRECTION FOR HEMATOCRITIC NUMBER | |
MX2012014281A (en) | Underfill management system for a biosensor. | |
JP2009535651A5 (en) | ||
RU2009114746A (en) | METHOD FOR DETERMINING HYDROGEN PEROXIDE CONCENTRATIONS | |
WO2011079937A3 (en) | Method for measuring analyte concentration in a liquid sample | |
KR101730288B1 (en) | Methods of electrochemically measuring an analyte with a test sequence having a pulsed dc block as well as devices, apparatuses and systems incorporating the same | |
JP2016510124A5 (en) | ||
CA2811851C (en) | Systems and methods of discriminating between a control sample and a test fluid using capacitance | |
Li et al. | Differential pulsed amperometry coupled to microchip capillary electrophoresis | |
WO2009027708A3 (en) | Pulsed electrochemical sensor | |
US20150276650A1 (en) | Method for fast measurement of specimen concentration | |
TWI589867B (en) | Quickly measure the concentration of the sample | |
AU2016213744A1 (en) | Gated amperometry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ LIU, ZUIFANG; MCNEILAGE, ALAN; STEELE, DOMINIC AND DEAKIN, SHERINE |
|
MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |